Pfizer enlisted the help of Ontario researchers to find molecular signatures that can be used to personalize treatments in its pipeline for colorectal cancer.
Helicos, Agencourt, Illumina, RainDance Technologies, Ontario Institute for Cancer Research, VWR International, ZyGem, University of Queensland, University of Michigan, Genomatix
Australia's National Health and Medical Research Council has awarded the University of Queensland about US$19.3 million to support it's cancer genome sequencing project aimed at characterizing pancreatic and ovarian cancers.
In an online commentary in CMAJ, an OICR official argues that if Canada's support of personalized medicine can't compete with other regions, the country will lose commercialization opportunities.
A team of Ontario researchers has identified a six-gene signature that can help predict non-small cell lung cancer outcomes — and uncovered evidence that there may be thousands of alternative prognostic signatures for the disease.
In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.
